Cyp2b3 (cytochrome P450, family 2, subfamily b, polypeptide 3) - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Behavioral & Substance Use Disorder Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)
Gene: Cyp2b3 (cytochrome P450, family 2, subfamily b, polypeptide 3) Rattus norvegicus
Analyze
Symbol: Cyp2b3
Name: cytochrome P450, family 2, subfamily b, polypeptide 3
RGD ID: 628627
Description: Predicted to enable heme binding activity and monooxygenase activity. Involved in response to Aroclor 1254. Predicted to be located in endoplasmic reticulum membrane. Predicted to be active in cytoplasm. Human ortholog(s) of this gene implicated in several diseases, including acute myeloid leukemia; drug dependence (multiple); human immunodeficiency virus infectious disease; neonatal abstinence syndrome; and nicotine dependence. Orthologous to human CYP2B6 (cytochrome P450 family 2 subfamily B member 6); PARTICIPATES IN acetylsalicylic acid pharmacodynamics pathway; antipyrine drug pathway; arachidonic acid metabolic pathway; INTERACTS WITH (+)-schisandrin B; 1-naphthyl isothiocyanate; 17beta-estradiol.
Type: protein-coding
RefSeq Status: VALIDATED
Previously known as: Cyp2b6; CYPIIB3; cytochrome P450 2B3; cytochrome P450 2B3-like; cytochrome P450, subfamily IIB (phenobarbital-inducible), polypeptide 6; cytochrome P450IIB3
RGD Orthologs
Human
Mouse
Bonobo
Dog
Pig
Green Monkey
Alliance Orthologs
More Info more info ...
Latest Assembly: GRCr8 - GRCr8 Assembly
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr8190,780,468 - 90,859,852 (+)NCBIGRCr8GRCr8GRCr8
mRatBN7.2181,652,762 - 81,732,153 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl181,652,787 - 81,732,143 (+)EnsemblmRatBN7.2
UTH_Rnor_SHR_Utx187,073,523 - 87,141,243 (+)NCBIUTH_Rnor_SHR_UtxUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0195,571,804 - 95,642,315 (+)NCBIUTH_Rnor_SHRSP_BbbUtx_1.0UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0188,829,353 - 88,897,077 (+)NCBIUTH_Rnor_WKY_Bbb_1.0UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0183,163,103 - 83,236,615 (+)NCBIRnor_6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl183,163,079 - 83,236,615 (+)Ensemblrn6Rnor6.0
Rnor_5.0184,445,481 - 84,491,180 (+)NCBIRnor_5.0Rnor_5.0rn5
RGSC_v3.4181,084,984 - 81,185,251 (+)NCBIRGSC_v3.4RGSC_v3.4rn4
Celera176,082,604 - 76,158,885 (+)NCBICelera
RGSC_v3.1181,486,546 - 81,659,871 (+)NCBI
Cytogenetic Map1q21NCBI
JBrowse:




Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(+)-artemisinin  (ISO)
(+)-catechin  (ISO)
(+)-epicatechin-3-O-gallate  (ISO)
(+)-isoborneol  (ISO)
(+)-Nornicotine  (ISO)
(+)-schisandrin B  (EXP)
(-)-anisomycin  (ISO)
(-)-cotinine  (ISO)
(-)-epigallocatechin 3-gallate  (ISO)
(-)-selegiline  (ISO)
(-)-trans-epsilon-viniferin  (ISO)
(1->4)-beta-D-glucan  (ISO)
(2E,4E)-hexa-2,4-dienoic acid  (ISO)
(E)-roxithromycin  (ISO)
(E,E)-germacrone  (ISO)
(R)-camphor  (ISO)
(R,R,R)-alpha-tocopherol  (ISO)
(S)-nicotine  (ISO)
1,1,1-Trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane  (ISO)
1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane  (ISO)
1,2-dichloroethane  (ISO)
1,4-dichlorobenzene  (ISO)
1,4-naphthoquinone  (ISO)
1,8-cineole  (ISO)
1-\{2-[(4-chlorobenzyl)sulfanyl]-2-(2,4-dichlorophenyl)ethyl\}-1H-imidazole  (ISO)
1-naphthol  (ISO)
1-naphthyl isothiocyanate  (EXP,ISO)
17alpha-ethynylestradiol  (ISO)
17beta-estradiol  (EXP,ISO)
2,2',3,3',6,6'-hexachlorobiphenyl  (ISO)
2,2',4,4',5,5'-hexachlorobiphenyl  (ISO)
2,2',4,4'-Tetrabromodiphenyl ether  (ISO)
2,2',4,5'-Tetrabromodiphenyl ether  (ISO)
2,3',4,4',5-Pentachlorobiphenyl  (ISO)
2,3,4,3',4'-Pentachlorobiphenyl  (ISO)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2,4,6-Triphenyl-1-hexene  (ISO)
2,4-dibromophenyl 2,4,5-tribromophenyl ether  (ISO)
2,6-di-tert-butyl-4-methylphenol  (ISO)
2,8-bis-Trifluoromethyl-4-quinoline carboxylic acid  (ISO)
2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile  (ISO)
2-chloroacetamide  (ISO)
2-Dechloroethylifosfamide  (ISO)
2-n-Propyl-4-pentenoic acid  (ISO)
2-Naphthalenethiol  (ISO)
2-naphthol  (ISO)
2-nitroanisole  (ISO)
2-nitrophenol  (EXP,ISO)
2-nitrotoluene  (ISO)
3,3',4,4',5-pentachlorobiphenyl  (EXP,ISO)
3,3',5,5'-tetrabromobisphenol A  (EXP)
3,5-diethoxycarbonyl-1,4-dihydrocollidine  (ISO)
3,5-xylenol  (ISO)
3-chloropropane-1,2-diol  (EXP)
3-methylcholanthrene  (EXP,ISO)
3H-1,2-dithiole-3-thione  (EXP)
4,4'-sulfonyldiphenol  (ISO)
4-(methylsulfinyl)phenol  (ISO)
4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one  (ISO)
4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol  (ISO)
4-Aminophenyl ether  (ISO)
4-bromo-2-chlorophenol  (ISO)
4-Hydroxy-N-desmethyltamoxifen  (ISO)
4-hydroxycyclophosphamide  (ISO)
4-hydroxynon-2-enal  (ISO)
4-Hydroxyvalproic acid  (ISO)
4-nonylphenol  (ISO)
5-hydroxydiclofenac  (ISO)
5-Hydroxyflavone  (ISO)
5-Hydroxyvalproic acid  (ISO)
5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole  (EXP,ISO)
5-methoxy-N,N-diisopropyltryptamine  (ISO)
5-methoxyindole  (ISO)
5-methyltryptamine  (ISO)
5alpha-androst-16-en-3alpha-ol  (ISO)
6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime  (ISO)
6-propyl-2-thiouracil  (EXP,ISO)
7,12-dimethyltetraphene  (ISO)
9-cis-retinoic acid  (ISO)
AB-Fubinaca  (ISO)
acetamide  (EXP)
acetochlor  (ISO)
acifluorfen  (ISO)
acrylamide  (EXP)
actinomycin D  (ISO)
afimoxifene  (ISO)
aflatoxin B1  (ISO)
AICA ribonucleotide  (EXP)
alachlor  (ISO)
aldehydo-D-glucose  (ISO)
aldrin  (ISO)
all-trans-retinoic acid  (ISO)
allocholic acid  (ISO)
allyl isothiocyanate  (ISO)
Aloe emodin  (ISO)
alpha-methyltryptamine  (ISO)
aminoguanidine  (ISO)
amiodarone  (EXP,ISO)
amitriptyline  (ISO)
amitriptylinoxide  (ISO)
amlodipine  (ISO)
amodiaquine  (ISO)
amphetamine  (ISO)
andrographolide  (ISO)
androst-4-ene-3,17-dione  (ISO)
androstane  (ISO)
aniline  (ISO)
arachidonic acid  (ISO)
Aroclor 1254  (EXP,ISO)
arsane  (ISO)
arsenic atom  (ISO)
arsenous acid  (ISO)
artemether  (ISO)
atazanavir sulfate  (ISO)
atorvastatin calcium  (ISO)
atrazine  (EXP,ISO)
Avasimibe  (ISO)
Azoxymethane  (ISO)
azoxystrobin  (ISO)
baicalein  (ISO)
barnidipine  (ISO)
benfuracarb  (ISO)
benidipine  (ISO)
benzbromarone  (EXP)
benzo[a]pyrene  (ISO)
benzo[a]pyrene diol epoxide I  (ISO)
benzo[b]fluoranthene  (ISO)
Benzo[k]fluoranthene  (ISO)
benzphetamine  (ISO)
berberine  (ISO)
bergomottin  (ISO)
beta-carboline  (ISO)
beta-hexachlorocyclohexane  (ISO)
beta-naphthoflavone  (ISO)
bexarotene  (ISO)
bilirubin IXalpha  (ISO)
bis(2-chloroethyl) sulfide  (ISO)
bis(2-ethylhexyl) adipate  (ISO)
bis(2-ethylhexyl) phthalate  (ISO)
bisphenol A  (EXP,ISO)
bisphenol F  (ISO)
bosentan  (ISO)
brequinar  (ISO)
brucine  (EXP)
bupropion  (ISO)
buta-1,3-diene  (ISO)
butachlor  (ISO)
butylated hydroxyanisole  (ISO)
Butylbenzyl phthalate  (ISO)
butyric acid  (ISO)
C.I. Natural Red 20  (ISO)
C60 fullerene  (EXP)
cadmium atom  (EXP,ISO)
cadmium dichloride  (EXP)
calciol  (ISO)
camphor  (ISO)
camptothecin  (ISO)
cannabidiol  (ISO)
captan  (ISO)
carbamazepine  (ISO)
carbaryl  (ISO)
carbendazim  (ISO)
carbofuran  (ISO)
carbosulfan  (ISO)
carnosic acid  (ISO)
cerivastatin  (ISO)
CGP 52608  (ISO)
Chalepensin  (ISO)
chenodeoxycholic acid  (ISO)
chlordecone  (ISO)
chlorfluazuron  (ISO)
chlorotoluron  (ISO)
chlorpromazine  (ISO)
chlorpyrifos  (ISO)
cholesterol  (ISO)
cholic acid  (ISO)
choline  (ISO)
chrysin  (ISO)
chrysophanol  (ISO)
ciguatoxin CTX1B  (ISO)
cimetidine  (ISO)
ciprofibrate  (ISO)
citral  (ISO)
clemizole  (ISO)
clofibrate  (EXP,ISO)
clopidogrel  (ISO)
clorgyline  (ISO)
clothianidin  (ISO)
clotrimazole  (ISO)
cobalt dichloride  (EXP,ISO)
copper(II) chloride  (ISO)
copper(II) sulfate  (ISO)
corticosterone  (ISO)
crocidolite asbestos  (ISO)
cumene hydroperoxide  (EXP)
cyanocob(III)alamin  (ISO)
cyclophosphamide  (EXP,ISO)
cyclosporin A  (ISO)
cyhalothrin  (ISO)
cylindrospermopsin  (ISO)
cypermethrin  (ISO)
cyproconazole  (ISO)
cyproterone  (ISO)
cyproterone acetate  (ISO)
D-glucose  (ISO)
dapsone  (ISO)
DDD  (ISO)
DDE  (ISO)
DDT  (EXP,ISO)
decabromodiphenyl ether  (ISO)
Dechloroethylcyclophosphamide  (ISO)
deoxycholic acid  (ISO)
dexamethasone  (EXP,ISO)
dextran sulfate  (ISO)
dextromethorphan  (ISO)
diallyl disulfide  (ISO)
Diallyl sulfide  (ISO)
diarsenic trioxide  (ISO)
diarylheptanoid  (ISO)
diazepam  (ISO)
diazinon  (ISO)
dibenz[a,h]anthracene  (ISO)
diclofenac  (ISO)
dicyclanil  (ISO)
dieldrin  (ISO)
diethylstilbestrol  (ISO)
difenoconazole  (ISO)
digitonin  (ISO)
dihydroergotamine  (ISO)
diiodine  (ISO)
dimemorfan  (ISO)
dimethyl sulfoxide  (ISO)
diquat  (ISO)
disodium selenite  (ISO)
diuron  (ISO)
domperidone  (ISO)
doxorubicin  (ISO)
dronedarone  (ISO)
efavirenz  (ISO)
elemental selenium  (ISO)
endosulfan  (ISO)
endrin  (ISO)
enilconazole  (ISO)
epoxiconazole  (ISO)
Erionite  (ISO)
erlotinib hydrochloride  (ISO)
estriol  (ISO)
estrone  (ISO)
ethanol  (ISO)
ethoxyquin  (ISO)
farnesol  (ISO)
felodipine  (ISO)
fenbuconazole  (ISO)
fenitrothion  (ISO)
fenofibrate  (ISO)
fenproporex  (ISO)
fentanyl  (ISO)
fenvalerate  (ISO)
finasteride  (EXP)
fipronil  (ISO)
flavonoids  (EXP)
fluconazole  (ISO)
fludioxonil  (ISO)
flumequine  (ISO)
fluoranthene  (ISO)
flutamide  (EXP)
fluvastatin  (ISO)
fluxapyroxad  (ISO)
folic acid  (ISO)
fructose  (ISO)
fulvestrant  (ISO)
furathiocarb  (ISO)
galangin  (ISO)
gallocatechin  (ISO)
gamma-hexachlorocyclohexane  (ISO)
geranial  (ISO)
geraniol  (ISO)
Ginkgolide A  (ISO)
ginkgolide B  (ISO)
ginsenoside Rg1  (EXP)
glucose  (ISO)
glutathione  (ISO)
glycine betaine  (ISO)
glycochenodeoxycholic acid  (ISO)
glycocholic acid  (ISO)
glycodeoxycholic acid  (ISO)
glyphosate  (ISO)
griseofulvin  (ISO)
guggulsterone  (ISO)
GW 3965  (ISO)
GW 4064  (ISO)
GW 7647  (ISO)
halothane  (ISO)
helenalin  (ISO)
herbicide  (ISO)
heroin  (ISO)
hexaflumuron  (ISO)
hexane  (ISO)
hydroquinone  (ISO)
Hydroxybupropion  (ISO)
hyperforin  (ISO)
ifosfamide  (ISO)
imidacloprid  (ISO)
imidazoles  (ISO)
imipramine oxide  (ISO)
imperatorin  (ISO)
indometacin  (EXP)
inulin  (ISO)
isoimperatorin  (ISO)
isopimpinellin  (ISO)
isoprenaline  (ISO)
isoproturon  (ISO)
isoxazoles  (ISO)
Isradipine  (ISO)
ivermectin  (ISO)
ketoconazole  (ISO)
kojic acid  (ISO)
L-ascorbic acid  (ISO)
L-ethionine  (EXP)
L-methionine  (ISO)
lactacystin  (ISO)
lamotrigine  (ISO)
lead diacetate  (ISO)
lefetamine  (ISO)
leflunomide  (ISO)
lithocholic acid  (ISO)
lycopene  (ISO)
malathion  (ISO)
mancozeb  (ISO)
Meclizine  (ISO)
mefenacet  (ISO)
MeIQx  (ISO)
mephenytoin  (ISO)
mercury dichloride  (ISO)
metazachlor  (ISO)
metformin  (ISO)
methidathion  (ISO)
methiocarb  (ISO)
methiocarb-sulfoxide  (ISO)
methoxsalen  (ISO)
methoxychlor  (ISO)
methoxyflurane  (ISO)
methylisothiazolinone  (ISO)
metolachlor  (ISO)
midazolam  (ISO)
mifepristone  (ISO)
mirex  (ISO)
Mitotane  (ISO)
Moniliformin  (ISO)
mono(2-ethylhexyl) phthalate  (ISO)
monocrotaline  (ISO)
monocrotophos  (ISO)
monosodium L-glutamate  (ISO)
moricizine  (ISO)
morphine  (ISO)
N'-Nitrosonornicotine  (ISO)
N,N-diethyl-m-toluamide  (ISO)
N,N-diisopropyltryptamine  (ISO)
N-[3-(aminomethyl)benzyl]acetamidine  (ISO)
N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal  (ISO)
N-Nitrosodi-n-propylamine  (ISO)
N-nitrosodiethylamine  (ISO)
NADP zwitterion  (ISO)
NADP(+)  (ISO)
nefazodone  (EXP,ISO)
nevirapine  (ISO)
nickel atom  (ISO)
nickel sulfate  (ISO)
nicotine  (ISO)
Nicotine imine  (ISO)
nifedipine  (ISO)
nimesulide  (EXP,ISO)
nitrapyrin  (ISO)
Nonylphenol  (ISO)
norflurazon  (ISO)
Notopterol  (ISO)
o-anisidine  (ISO)
O-methyleugenol  (ISO)
ochratoxin A  (ISO)
Octachlorostyrene  (ISO)
okadaic acid  (ISO)
oleanolic acid  (ISO)
oleic acid  (ISO)
oltipraz  (ISO)
omeprazole  (EXP,ISO)
orphenadrine  (ISO)
ortho-Aminoazotoluene  (ISO)
Oxadiazon  (ISO)
oxazepam  (ISO)
oxolane  (ISO)
oxybenzone  (EXP)
Oxyfluorfen  (ISO)
ozone  (ISO)
p-menthan-3-ol  (ISO)
Panaxytriol  (ISO)
paracetamol  (ISO)
paraquat  (ISO)
parathion  (ISO)
Pargyline  (ISO)
paricalcitol  (ISO)
paroxetine  (ISO)
pazopanib  (ISO)
pencycuron  (ISO)
pendimethalin  (ISO)
pentachlorophenol  (ISO)
perflubutane  (ISO)
perfluorobutanesulfonic acid  (ISO)
perfluorodecanoic acid  (ISO)
perfluorododecanoic acid  (ISO)
perfluoroheptanoic acid  (ISO)
perfluorohexanesulfonic acid  (ISO)
perfluorohexanoic acid  (ISO)
perfluorononanoic acid  (ISO)
perfluorooctane-1-sulfonic acid  (EXP,ISO)
perfluorooctanoic acid  (EXP,ISO)
perfluoroundecanoic acid  (ISO)
perillyl aldehyde  (ISO)
permethrin  (ISO)
phenanthrene  (ISO)
phencyclidine  (ISO)
Phenelzine  (ISO)
phenethyl isothiocyanate  (ISO)
phenobarbital  (EXP,ISO)
phenthoate  (ISO)
phenytoin  (ISO)
phlorizin  (ISO)
phorone  (ISO)
phosphorus atom  (ISO)
phosphorus(.)  (ISO)
physcion  (ISO)
piclamilast  (ISO)
pimecrolimus  (ISO)
pioglitazone  (ISO)
piperonyl butoxide  (ISO)
pirinixic acid  (EXP,ISO)
PK-11195  (ISO)
pravastatin  (ISO)
pregnenolone 16alpha-carbonitrile  (EXP,ISO)
primaquine  (ISO)
prochloraz  (ISO)
profenofos  (ISO)
progesterone  (ISO)
propiconazole  (EXP,ISO)
propofol  (ISO)
propyzamide  (ISO)
pterostilbene  (ISO)
pyrene  (ISO)
pyrethrins  (ISO)
quercetin  (ISO)
quinidine  (ISO)
reserpine  (ISO)
resveratrol  (ISO)
retinyl acetate  (ISO)
rifampicin  (ISO)
ritonavir  (ISO)
romidepsin  (ISO)
selenium atom  (ISO)
senecionine  (ISO)
sertraline  (ISO)
Shikonin  (ISO)
sibutramine  (ISO)
simvastatin  (ISO)
sirolimus  (ISO)
sodium arsenite  (ISO)
sodium dichromate  (EXP,ISO)
steviol  (ISO)
streptozocin  (ISO)
succimer  (ISO)
Sudan I  (ISO)
sulconazole  (ISO)
sulfasalazine  (ISO)
sulfinpyrazone  (ISO)
sulfluramid  (ISO)
sulfoxaflor  (ISO)
tamoxifen  (ISO)
tartrazine  (ISO)
tauroursodeoxycholic acid  (EXP)
tebuconazole  (ISO)
tebufenozide  (ISO)
teriflunomide  (ISO)
tert-butanol  (ISO)
testosterone  (ISO)
tetrachloroethene  (ISO)
tetrachloromethane  (EXP,ISO)
tetrahydrocurcumin  (ISO)
thalidomide  (ISO)
Theaflavin 3,3'-digallate  (ISO)
thiabendazole  (ISO)
thiacloprid  (ISO)
thioacetamide  (EXP)
thiophanate-methyl  (ISO)
Thiotepa  (ISO)
ticlopidine  (ISO)
tienilic acid  (ISO)
tirapazamine  (ISO)
titanium dioxide  (ISO)
toxaphene  (ISO)
tranylcypromine  (ISO)
tremolite asbestos  (ISO)
triadimefon  (EXP,ISO)
trichloroethene  (ISO)
triclocarban  (ISO)
triclosan  (ISO)
triflumuron  (ISO)
trifluralin  (ISO)
triphenyl phosphate  (ISO)
Triptolide  (ISO)
triptonide  (ISO)
Tris(1-aziridinyl)phosphine oxide  (ISO)
troglitazone  (ISO)
tryptamines  (ISO)
ursodeoxycholic acid  (EXP,ISO)
valproic acid  (ISO)
vatalanib  (ISO)
verapamil  (ISO)
verteporfin  (ISO)
VX nerve agent  (ISO)
warfarin  (ISO)
zaragozic acid A  (ISO)
zinc atom  (ISO)
zinc(0)  (ISO)
ziram  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process

Cellular Component

Molecular Pathway Annotations     Click to see Annotation Detail View
acetylsalicylic acid pharmacodynamics pathway  (ISO)
antipyrine drug pathway  (ISO)
arachidonic acid metabolic pathway  (IEA,ISO)
carbamazepine pharmacokinetics pathway  (ISO)
celecoxib pharmacodynamics pathway  (ISO)
clopidogrel pharmacodynamics pathway  (ISO)
clopidogrel pharmacokinetics pathway  (ISO)
cyclophosphamide pharmacodynamics pathway  (ISO)
cyclophosphamide pharmacokinetics pathway  (ISO)
diclofenac pharmacodynamics pathway  (ISO)
diflunisal pharmacodynamics pathway  (ISO)
etodolac pharmacodynamics pathway  (ISO)
fenoprofen pharmacodynamics pathway  (ISO)
flurbiprofen pharmacodynamics pathway  (ISO)
ibuprofen pharmacodynamics pathway  (ISO)
ifosfamide pharmacodynamics pathway  (ISO)
ifosfamide pharmacokinetics pathway  (ISO)
indometacin pharmacodynamics pathway  (ISO)
indometacin pharmacodynamics pathway  (ISO)
ketoprofen pharmacodynamics pathway  (ISO)
ketorolac pharmacodynamics pathway  (ISO)
leukotriene C4 synthase deficiency pathway  (ISO)
lornoxicam pharmacodynamics pathway  (ISO)
magnesium salicylate pharmacodynamics pathway  (ISO)
mefenamic acid pharmacodynamics pathway  (ISO)
meloxicam pharmacodynamics pathway  (ISO)
methadone pharmacodynamics pathway  (ISO)
methadone pharmacokinetics pathway  (ISO)
nabumetone pharmacodynamics pathway  (ISO)
naproxen pharmacodynamics pathway  (ISO)
neviparine pharmacokinetics pathway  (ISO)
nicotine pharmacodynamics pathway  (ISO)
nicotine pharmacokinetics pathway   (ISO)
organophosphate response pathway   (ISO)
paracetamol drug pathway  (ISO)
phase I biotransformation pathway via cytochrome P450  (IEA)
piroxicam pharmacodynamics pathway   (ISO)
retinol metabolic pathway  (IEA,ISO)
salicylic acid pharmacodynamics pathway  (ISO)
sodium salicylate pharmacodynamics pathway  (ISO)
sorafenib pharmacokinetics pathway  (ISO)
sulindac pharmacodynamics pathway   (ISO)
tamoxifen pharmacodynamics pathway   (ISO)
tamoxifen pharmacokinetics pathway  (ISO)
tenoxicam pharmacodynamics pathway  (ISO)
tiaprofenic acid pharmacodynamics pathway  (ISO)
tolmetin pharmacodynamics pathway  (ISO)
tramadol pharmacokinetics pathway  (ISO)
valdecoxib pharmacodynamics pathway  (ISO)
valproic acid pharmacokinetics pathway  (ISO)
vitamin A deficiency pathway  (ISO)

References

References - curated
# Reference Title Reference Citation
1. Tell-Tale SNPs: The Role of CYP2B6 in Methadone Fatalities. Ahmad T, etal., J Anal Toxicol. 2017 May 1;41(4):325-333. doi: 10.1093/jat/bkw135.
2. Precision therapeutic opioid dosing implications from genetic biomarkers and craving score. Chang HW, etal., Medicine (Baltimore). 2020 May 29;99(22):e20429. doi: 10.1097/MD.0000000000020429.
3. Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. David SP, etal., Nicotine Tob Res. 2007 Aug;9(8):821-33.
4. New proteins in the rat CYP2B subfamily: presence in liver microsomes of the constitutive CYP2B3 protein and the phenobarbital-inducible protein product of alternatively spliced CYP2B2 mRNA. Desrochers M, etal., Biochem Pharmacol. 1996 Oct 25;52(8):1311-9.
5. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
6. A constitutive member of the rat cytochrome P450IIB subfamily: full-length coding sequence of the P450IIB3 cDNA. Labbe D, etal., DNA 1988 May;7(4):253-60.
7. CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial. Lee AM, etal., Biol Psychiatry. 2007 Sep 15;62(6):635-41. doi: 10.1016/j.biopsych.2006.10.005. Epub 2007 Jan 16.
8. Moving toward personalized medicine in the methadone maintenance treatment program: a pilot study on the evaluation of treatment responses in Taiwan. Lee HY, etal., Biomed Res Int. 2013;2013:741403. doi: 10.1155/2013/741403. Epub 2013 Dec 16.
9. CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction. Levran O, etal., Addict Biol. 2013 Jul;18(4):709-16. doi: 10.1111/j.1369-1600.2011.00349.x. Epub 2011 Jul 25.
10. Opiate exposure and withdrawal dynamically regulate mRNA expression in the serotonergic dorsal raphe nucleus. Lunden JW and Kirby LG, Neuroscience. 2013 Dec 19;254:160-72. doi: 10.1016/j.neuroscience.2013.08.071. Epub 2013 Sep 20.
11. Variations in Infant CYP2B6 Genotype Associated with the Need for Pharmacological Treatment for Neonatal Abstinence Syndrome in Infants of Methadone-Maintained Opioid-Dependent Mothers. Mactier H, etal., Am J Perinatol. 2017 Jul;34(9):918-921. doi: 10.1055/s-0037-1600917. Epub 2017 Mar 20.
12. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
13. SMPDB Annotation Import Pipeline Pipeline to import SMPDB annotations from SMPDB into RGD
14. GOA pipeline RGD automated data pipeline
15. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
16. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
17. CYP2B6 gene single-nucleotide polymorphisms in an Italian population sample and relationship with nicotine dependence. Riccardi LN, etal., Genet Test Mol Biomarkers. 2015 Feb;19(2):103-7. doi: 10.1089/gtmb.2014.0239. Epub 2014 Dec 9.
18. Different expression of hepatic and renal cytochrome P450s between the streptozotocin-induced diabetic mouse and rat. Sakuma T, etal., Xenobiotica. 2001 Apr;31(4):223-37.
19. CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy. Tomaz PR, etal., Eur J Clin Pharmacol. 2015 Sep;71(9):1067-73. doi: 10.1007/s00228-015-1896-x. Epub 2015 Jul 8.
20. High efavirenz serum concentrations in TB/HIV-coinfected Ugandan adults with a CYP2B6 516 TT genotype on anti-TB treatment. von Braun A, etal., J Antimicrob Chemother. 2019 Jan 1;74(1):135-138. doi: 10.1093/jac/dky379.
21. Association of CYP2B6 gene polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese population. Wang Y, etal., Infect Genet Evol. 2017 Jul;51:198-202. doi: 10.1016/j.meegid.2017.04.001. Epub 2017 Apr 5.
22. Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients. Wyen C, etal., J Antimicrob Chemother. 2008 Apr;61(4):914-8. doi: 10.1093/jac/dkn029. Epub 2008 Feb 14.
23. High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naive HIV patients from Ethiopia: a prospective cohort study. Yimer G, etal., Pharmacogenomics J. 2012 Dec;12(6):499-506. doi: 10.1038/tpj.2011.34. Epub 2011 Aug 23.
24. Relationship between CYP2B6*6 and cold pressor pain sensitivity in opioid dependent patients on methadone maintenance therapy (MMT). Zahari Z, etal., Drug Alcohol Depend. 2016 Aug 1;165:143-50. doi: 10.1016/j.drugalcdep.2016.05.028. Epub 2016 Jun 6.
Additional References at PubMed
PMID:3013548   PMID:6885818   PMID:8068203   PMID:12477932   PMID:12865317   PMID:15489334   PMID:17086191   PMID:18356043   PMID:19029318   PMID:19651758   PMID:20061448   PMID:21289075  


Genomics

Comparative Map Data
Cyp2b3
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr8190,780,468 - 90,859,852 (+)NCBIGRCr8GRCr8GRCr8
mRatBN7.2181,652,762 - 81,732,153 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl181,652,787 - 81,732,143 (+)EnsemblmRatBN7.2
UTH_Rnor_SHR_Utx187,073,523 - 87,141,243 (+)NCBIUTH_Rnor_SHR_UtxUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0195,571,804 - 95,642,315 (+)NCBIUTH_Rnor_SHRSP_BbbUtx_1.0UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0188,829,353 - 88,897,077 (+)NCBIUTH_Rnor_WKY_Bbb_1.0UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0183,163,103 - 83,236,615 (+)NCBIRnor_6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl183,163,079 - 83,236,615 (+)Ensemblrn6Rnor6.0
Rnor_5.0184,445,481 - 84,491,180 (+)NCBIRnor_5.0Rnor_5.0rn5
RGSC_v3.4181,084,984 - 81,185,251 (+)NCBIRGSC_v3.4RGSC_v3.4rn4
Celera176,082,604 - 76,158,885 (+)NCBICelera
RGSC_v3.1181,486,546 - 81,659,871 (+)NCBI
Cytogenetic Map1q21NCBI
CYP2B6
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh381940,991,282 - 41,018,398 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl1940,991,281 - 41,018,398 (+)Ensemblhg38GRCh38
GRCh371941,497,187 - 41,524,303 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 361946,189,044 - 46,216,141 (+)NCBIBuild 36Build 36hg18NCBI36
Build 341946,189,043 - 46,216,141NCBI
Celera1938,297,361 - 38,324,463 (+)NCBICelera
Cytogenetic Map19q13.2NCBI
HuRef1937,929,211 - 37,956,335 (+)NCBIHuRef
CHM1_11941,496,934 - 41,524,020 (+)NCBICHM1_1
T2T-CHM13v2.01943,812,191 - 43,839,297 (+)NCBIT2T-CHM13v2.0
Cyp2b10
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm39725,597,083 - 25,626,049 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl725,597,045 - 25,626,049 (+)EnsemblGRCm39 EnsemblGRCm39
GRCm38725,897,658 - 25,926,624 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl725,897,620 - 25,926,624 (+)Ensemblmm10GRCm38
MGSCv37726,682,683 - 26,711,643 (+)NCBIMGSCv37MGSCv37mm9NCBIm37
MGSCv36725,606,424 - 25,635,384 (+)NCBIMGSCv36mm8
Celera720,506,748 - 20,536,205 (+)NCBICelera
Cytogenetic Map7A3NCBI
cM Map714.11NCBI
CYP2B6
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan1-v22047,220,446 - 47,246,316 (+)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan11949,088,771 - 49,114,653 (+)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v01938,003,083 - 38,028,980 (+)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.11946,509,370 - 46,534,672 (+)NCBIPanPan1.1PanPan1.1panPan2
PanPan1.1 Ensembl1946,509,370 - 46,534,672 (+)EnsemblpanPan2panpan1.1
CYP2B6
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.11112,817,561 - 112,833,294 (+)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl1112,816,502 - 112,833,293 (+)EnsemblcanFam3CanFam3.1
Dog10K_Boxer_Tasha1112,220,751 - 112,236,323 (+)NCBIDog10K_Boxer_TashaDog10K_Boxer_Tasha
ROS_Cfam_1.01113,415,892 - 113,431,675 (+)NCBIROS_Cfam_1.0ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl1113,415,766 - 113,431,674 (+)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.11112,976,144 - 112,991,691 (+)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.01112,607,509 - 112,623,091 (+)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.01113,602,017 - 113,617,585 (+)NCBIUU_Cfam_GSD_1.0UU_Cfam_GSD_1.0
CYP2B6B
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl649,110,812 - 49,178,334 (-)EnsemblsusScr11Sscrofa11.1
Sscrofa11.1649,158,175 - 49,173,872 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.2644,968,257 - 44,978,794 (+)NCBISscrofa10.2Sscrofa10.2susScr3
CYP2B6
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.1635,392,699 - 35,418,171 (+)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl635,393,342 - 35,418,106 (+)EnsemblChlSab1.1 EnsemblchlSab2Vervet-AGM
Vero_WHO_p1.0NW_02366607313,588,241 - 13,611,993 (+)NCBIVero_WHO_p1.0Vero_WHO_p1.0

Variants

.
Variants in Cyp2b3
379 total Variants
miRNA Target Status (No longer updated)

Predicted Target Of
Summary Value
Count of predictions:145
Count of miRNA genes:115
Interacting mature miRNAs:127
Transcripts:ENSRNOT00000034845
Prediction methods:Microtar, Miranda, Rnahybrid
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (GRCr8)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
1578649Bmd8Bone mineral density QTL 84.9femur mineral mass (VT:0010011)trabecular volumetric bone mineral density (CMO:0001729)151940904101229020Rat
1582234Gluco18Glucose level QTL 183.40.0003blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)187889942132889942Rat
1358359Sradr1Stress Responsive Adrenal Weight QTL 14.74adrenal gland mass (VT:0010420)both adrenal glands wet weight (CMO:0000164)139728272132889942Rat
4889929Bss87Bone structure and strength QTL 876.7tibia area (VT:1000281)tibia-fibula cortical bone endosteal cross-sectional area (CMO:0001722)14630261591302615Rat
634314Niddm44Non-insulin dependent diabetes mellitus QTL 44blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)151941022208479811Rat
2313062Bmd73Bone mineral density QTL 733.90.0001tibia mineral mass (VT:1000283)compact volumetric bone mineral density (CMO:0001730)14630261591302615Rat
1578654Bss10Bone structure and strength QTL 104femur morphology trait (VT:0000559)femoral neck cortical cross-sectional area (CMO:0001702)151940904168768703Rat
2313065Bss67Bone structure and strength QTL 673.10.0001tibia area (VT:1000281)tibia total energy absorbed before break (CMO:0001736)14630261591302615Rat
1331800Scl25Serum cholesterol level QTL 253.013blood cholesterol amount (VT:0000180)serum total cholesterol level (CMO:0000363)187785026142582336Rat
7421628Bp361Blood pressure QTL 3610.001arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)183019780128019780Rat
2313069Bss68Bone structure and strength QTL 682.90.0001tibia size trait (VT:0100001)tibia total energy absorbed before break (CMO:0001736)14630261591302615Rat
631495Bp96Blood pressure QTL 964.52arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)166404680111404680Rat
70225Bp58Blood pressure QTL 583.3arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)134184556172281316Rat
2313075Bss66Bone structure and strength QTL 663.40.0001tibia length (VT:0004357)tibia length (CMO:0000450)14630261591302615Rat
631512Scl6Serum cholesterol level QTL 69.6blood cholesterol amount (VT:0000180)serum total cholesterol level (CMO:0000363)18126986099645535Rat
2298545Neuinf8Neuroinflammation QTL 84.6nervous system integrity trait (VT:0010566)spinal cord beta-2 microglobulin mRNA level (CMO:0002125)166009857160501508Rat
10059597Bp377Blood pressure QTL 3773.420.025arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)134565911208798288Rat
2313077Bss69Bone structure and strength QTL 693.50.0001tibia strength trait (VT:1000284)bone polar moment of inertia (CMO:0001558)14630261591302615Rat
1302788Scl19Serum cholesterol QTL 194.60.001blood cholesterol amount (VT:0000180)plasma total cholesterol level (CMO:0000585)166400974132889942Rat
1549903Bp267Blood pressure QTL 267arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)184107164115183752Rat
2313402Anxrr24Anxiety related response QTL 24aggression-related behavior trait (VT:0015014)tameness/aggressiveness composite score (CMO:0002136)151511344153680016Rat
61342Bp27Blood pressure QTL 273.40.0006arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)16540563796805205Rat
4889962Bss94Bone structure and strength QTL 943.8tibia area (VT:1000281)tibia-fibula cortical bone endosteal cross-sectional area (CMO:0001722)15190920691302615Rat
1358192Ept13Estrogen-induced pituitary tumorigenesis QTL 133.4pituitary gland mass (VT:0010496)pituitary gland wet weight (CMO:0000853)186622262131622262Rat
6903308Scl36Serum cholesterol QTL 3620.0125blood cholesterol amount (VT:0000180)plasma total cholesterol level (CMO:0000585)158769992103769992Rat
2313092Bmd72Bone mineral density QTL 722.50.0001tibia mineral mass (VT:1000283)total volumetric bone mineral density (CMO:0001728)14630261591302615Rat
2300164Bmd44Bone mineral density QTL 445.40.0001lumbar vertebra mineral mass (VT:0010511)volumetric bone mineral density (CMO:0001553)166077886111077886Rat
2313097Bss70Bone structure and strength QTL 703.50.0001tibia strength trait (VT:1000284)tibia total energy absorbed before break (CMO:0001736)14630261591302615Rat
152025249Scl82Serum cholesterol level QTL 824.77blood cholesterol amount (VT:0000180)152891222109116986Rat
10054135Gmadr2Adrenal mass QTL 21.970.0129adrenal gland mass (VT:0010420)both adrenal glands wet weight (CMO:0000164)186993904131993904Rat
7411712Strs4Sensitivity to stroke QTL 48.7cerebrum integrity trait (VT:0010549)percentage of study population developing cerebrovascular lesions during a period of time (CMO:0000932)187558587132558587Rat
4889919Bss86Bone structure and strength QTL 864.1tibia area (VT:1000281)tibia midshaft total cross-sectional area (CMO:0001715)14630261591302615Rat

Markers in Region
D1Rat213  
Rat AssemblyChrPosition (strand)SourceJBrowse
GRCr8190,905,258 - 90,905,414 (+)Marker Load Pipeline
mRatBN7.2181,777,564 - 81,777,720 (+)MAPPERmRatBN7.2
Rnor_6.0183,282,659 - 83,282,814NCBIRnor6.0
Rnor_5.0184,537,073 - 84,537,228UniSTSRnor5.0
RGSC_v3.4181,548,754 - 81,548,909UniSTSRGSC3.4
RGSC_v3.4181,548,753 - 81,548,909RGDRGSC3.4
Celera176,204,150 - 76,204,305UniSTS
RGSC_v3.1181,626,865 - 81,627,020RGD
RH 3.4 Map1841.1RGD
RH 3.4 Map1841.1UniSTS
FHH x ACI Map142.2599UniSTS
FHH x ACI Map142.2599RGD
Cytogenetic Map1q21UniSTS


Expression

RNA-SEQ Expression

alimentary part of gastrointestinal system
appendage
circulatory system
ectoderm
endocrine system
endoderm
exocrine system
hemolymphoid system
hepatobiliary system
integumental system
mesenchyme
mesoderm
nervous system
renal system
reproductive system
respiratory system
5 8 14 34 68 72 48 17 48 6 124 44 20 20 28 24

Sequence


Ensembl Acc Id: ENSRNOT00000034845   ⟹   ENSRNOP00000030069
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl181,652,787 - 81,732,143 (+)Ensembl
Rnor_6.0 Ensembl183,163,100 - 83,236,615 (+)Ensembl
Ensembl Acc Id: ENSRNOT00000077725   ⟹   ENSRNOP00000074818
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
Rnor_6.0 Ensembl183,163,079 - 83,236,576 (+)Ensembl
RefSeq Acc Id: NM_173294   ⟹   NP_775416
RefSeq Status: VALIDATED
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr8190,780,492 - 90,859,852 (+)NCBI
mRatBN7.2181,652,785 - 81,732,153 (+)NCBI
Rnor_6.0183,163,103 - 83,236,615 (+)NCBI
Rnor_5.0184,445,481 - 84,491,180 (+)NCBI
Celera176,082,604 - 76,158,885 (+)RGD
Sequence:
RefSeq Acc Id: XM_039102697   ⟹   XP_038958625
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr8190,780,468 - 90,834,231 (+)NCBI
mRatBN7.2181,652,762 - 81,706,530 (+)NCBI
RefSeq Acc Id: NP_775416   ⟸   NM_173294
- Peptide Label: precursor
- UniProtKB: Q3B8R5 (UniProtKB/Swiss-Prot),   A1L121 (UniProtKB/Swiss-Prot),   Q64585 (UniProtKB/Swiss-Prot),   P13107 (UniProtKB/Swiss-Prot),   A6J997 (UniProtKB/TrEMBL)
- Sequence:
Ensembl Acc Id: ENSRNOP00000074818   ⟸   ENSRNOT00000077725
Ensembl Acc Id: ENSRNOP00000030069   ⟸   ENSRNOT00000034845
RefSeq Acc Id: XP_038958625   ⟸   XM_039102697
- Peptide Label: isoform X1
- UniProtKB: Q6LCX2 (UniProtKB/TrEMBL)

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P13107-F1-model_v2 AlphaFold P13107 1-491 view protein structure

Transcriptome

eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

Promoters
RGD ID:13689837
Promoter ID:EPDNEW_R361
Type:multiple initiation site
Name:Cyp2b3_1
Description:cytochrome P450, family 2, subfamily b, polypeptide 3
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Position:
Rat AssemblyChrPosition (strand)Source
Rnor_6.0183,163,101 - 83,163,161EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:628627 AgrOrtholog
BioCyc Gene G2FUF-60346 BioCyc
Ensembl Genes ENSRNOG00000033164 Ensembl, UniProtKB/Swiss-Prot
  ENSRNOG00000084200 ENTREZGENE
Ensembl Transcript ENSRNOT00000034845.6 UniProtKB/Swiss-Prot
  ENSRNOT00000047540 ENTREZGENE
Gene3D-CATH 1.10.630.10 UniProtKB/Swiss-Prot
IMAGE_CLONE IMAGE:7368614 IMAGE-MGC_LOAD
  IMAGE:7372256 IMAGE-MGC_LOAD
  IMAGE:7372728 IMAGE-MGC_LOAD
InterPro Cyt_P450 UniProtKB/Swiss-Prot
  Cyt_P450_CS UniProtKB/Swiss-Prot
  Cyt_P450_E_grp-I UniProtKB/Swiss-Prot
  Cyt_P450_E_grp-I_CYP2B-like UniProtKB/Swiss-Prot
  Cyt_P450_sf UniProtKB/Swiss-Prot
  Cytochrome_P450_fam2 UniProtKB/Swiss-Prot
KEGG Report rno:286953 UniProtKB/Swiss-Prot
MGC_CLONE MGC:108555 IMAGE-MGC_LOAD
  MGC:124933 IMAGE-MGC_LOAD
  MGC:156573 IMAGE-MGC_LOAD
NCBI Gene 286953 ENTREZGENE
PANTHER CYTOCHROME P450 2B6 UniProtKB/Swiss-Prot
  CYTOCHROME P450 508A4-RELATED UniProtKB/Swiss-Prot
Pfam p450 UniProtKB/Swiss-Prot
PhenoGen Cyp2b3 PhenoGen
PRINTS EP450I UniProtKB/Swiss-Prot
  EP450ICYP2B UniProtKB/Swiss-Prot
  P450 UniProtKB/Swiss-Prot
PROSITE CYTOCHROME_P450 UniProtKB/Swiss-Prot
RatGTEx ENSRNOG00000033164 RatGTEx
  ENSRNOG00000084200 RatGTEx
Superfamily-SCOP SSF48264 UniProtKB/Swiss-Prot
UniProt A1L121 ENTREZGENE
  A6J997 ENTREZGENE, UniProtKB/TrEMBL
  A6J998_RAT UniProtKB/TrEMBL
  CP2B3_RAT UniProtKB/Swiss-Prot, ENTREZGENE
  Q3B8R5 ENTREZGENE
  Q64585 ENTREZGENE
  Q6LCX1_RAT UniProtKB/TrEMBL
  Q6LCX2 ENTREZGENE, UniProtKB/TrEMBL
UniProt Secondary A1L121 UniProtKB/Swiss-Prot
  Q3B8R5 UniProtKB/Swiss-Prot
  Q64585 UniProtKB/Swiss-Prot


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2013-05-24 Cyp2b3  cytochrome P450, family 2, subfamily b, polypeptide 3  LOC100359973  cytochrome P450 2B3-like  Data merged from RGD:2323072 1643240 APPROVED
2010-05-06 LOC100359973  cytochrome P450 2B3-like      Symbol and Name status set to provisional 70820 PROVISIONAL
2010-04-19 Cyp2b3  cytochrome P450, family 2, subfamily b, polypeptide 3  Cyp2b3  cytochrome P450IIB3  Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2009-06-15 Cyp2b3  cytochrome P450IIB3  Cyp2b6  cytochrome P450, subfamily IIB (phenobarbital-inducible), polypeptide 6  Data merged from RGD:619923 1643240 APPROVED
2003-02-27 Cyp2b3  cytochrome P450IIB3      Symbol and Name status set to provisional 70820 PROVISIONAL
2002-08-07 Cyp2b6  cytochrome P450, subfamily IIB (phenobarbital-inducible), polypeptide 6      Symbol and Name status set to provisional 70820 PROVISIONAL